Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for severe COVID-19 differ by age for hospitalized adults
Sevda Molani, Patricia V. Hernandez, Ryan Roper, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Shedding of Infectious SARS-CoV-2 Despite Vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 117
Shedding of infectious SARS-CoV-2 despite vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010876-e1010876
Open Access | Times Cited: 76
The transition from genomics to phenomics in personalized population health
James T. Yurkovich, Simon J. Evans, Noa Rappaport, et al.
Nature Reviews Genetics (2023) Vol. 25, Iss. 4, pp. 286-302
Closed Access | Times Cited: 22
Kidney Transplant and Dialysis Patients Remain at Increased Risk for Succumbing to COVID-19
Anne Weiss, Rodinde Hendrickx, Eva Stensgaard, et al.
Transplantation (2022) Vol. 107, Iss. 5, pp. 1136-1138
Open Access | Times Cited: 24
Biological Age Predictors: The Status Quo and Future Trends
Veronika V. Erema, Anna Yurievna Yakovchik, Д. А. Каштанова, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15103-15103
Open Access | Times Cited: 23
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses
Muhannad Smadi, Melina Kaburis, Youval Schnapper, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 2, pp. 348-361
Open Access | Times Cited: 15
Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system
Qi Wei, Philip J. Mease, Michael Chiorean, et al.
The Lancet Digital Health (2024) Vol. 6, Iss. 5, pp. e309-e322
Open Access | Times Cited: 6
Outcomes and Adverse Effects of Baricitinib Versus Tocilizumab in the Management of Severe COVID-19*
Joy H. Peterson, Neha Paranjape, Nina Grundlingh, et al.
Critical Care Medicine (2022) Vol. 51, Iss. 3, pp. 337-346
Open Access | Times Cited: 19
Characterizing the clinical and economic burden of COVID-19 among individuals with immunocompromising conditions in Ontario, Canada – a matched, population-based observational study
Christina Qian, Karissa Johnston, María Tinajero, et al.
Journal of Medical Economics (2025), pp. 1-21
Open Access
Knowledge, attitudes, perceptions and reported uptake of COVID-19 vaccines among adults in Tanzania: a mid-pandemic population-based cross-sectional survey
Shubi Ambwene Matovelo, Deogratius Bintabara, Azan Nyundo, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Clinical, Biochemical, and ATR-FTIR Spectroscopic Parameters Associated with Death or Survival in Patients with Severe COVID-19
Adriana Martínez-Cuazitl, Mónica Maribel Mata-Miranda, Miguel Sánchez-Brito, et al.
Journal of Spectroscopy (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 8
Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients
Juan Carlos Borrego, María Julieta Cárdenas-de Luna, José Carlos Márquez-Castillo, et al.
Infectious Disease Reports (2024) Vol. 16, Iss. 3, pp. 458-471
Open Access | Times Cited: 2
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients
Renato Santos, Víctor Moreno‐Torres, Ilduara Pintos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Is Age the Most Important Risk Factor in COVID-19 Patients? The Relevance of Comorbidity Burden: A Retrospective Analysis of 10,551 Hospitalizations
Damià Valero-Bover, David Monterde, Gerard Carot-Sans, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 811-825
Open Access | Times Cited: 5
Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in Benin
Tomabu Adjobimey, Julia Meyer, Anneka Hennenfent, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study
Hoda Shirafkan, Farzin Sadeghi, Mehrdad Halaji, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis, Πέτρος Ιωάννου, Sotiris Tzalis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7172-7172
Open Access | Times Cited: 9
Distinct Clinical Presentations and Outcomes of Hospitalized Adults with the SARS-CoV-2 Infection Occurring during the Omicron Variant Surge
Jianli Niu, Myeongji Kim, Ayesha Tamkinat Jalal, et al.
Healthcare (2023) Vol. 11, Iss. 12, pp. 1703-1703
Open Access | Times Cited: 4
Age and political leaning predict COVID-19 vaccination status at a large, multi-campus, public university in Pennsylvania: A cross-sectional survey
Ryan Murphy, Lauren Pomerantz, Prabhani Kuruppumullage Don, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291974-e0291974
Open Access | Times Cited: 4
Impact and evolution of risk factors associated with hospitalization and mortality due to COVID-19 during the six epidemic waves in Mexico
Fernando Saldaña-Jiménez, F-Javier Almaguer, Francisco Hernández‐Cabrera, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27962-e27962
Open Access | Times Cited: 1
An Albumin, Neutrophil, and Lymphocyte-Related Risk Estimation Tool in Hospitalised Patients
Ethar N Ibrahim, Hisham A Alrashdan, Osama M Alshiyyab, et al.
Cureus (2024)
Open Access | Times Cited: 1
DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters
Tigran Harutyunyan, Anzhela Sargsyan, Lily Kalashyan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10293-10293
Open Access | Times Cited: 1
Clinical Characteristics and Prognostic Factors of COVID‐19 Patients Admitted to the National Treatment Center in The Gambia
Sheikh Omar Bittaye, Abubacarr Jagne, Abdul‐Karim Iddrisu, et al.
Advances in Public Health (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients
Lukas van de Sand, Peer Braß, Jonas Gregorius, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 283-283
Open Access | Times Cited: 6
Outpatient Intravenous Remdesivir to Prevent Progression to Severe COVID-19: An Observational Study from a Greek Hospital
Nikolaos Kintrilis, Iosif Galinos
Recent Advances in Anti-Infective Drug Discovery (2023) Vol. 19, Iss. 2, pp. 173-178
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top